Principles of laboratory assessment of drug abuse liability and implications for clinical development.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Drug and Alcohol Dependence

• Publication date

  2009-12-01

• Fields of study

  Law, Medicine

• Identifiers
  DOI 10.1016/j.drugalcdep.2009.04.003PMID 19443137PMCID PMC2763984
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of Withdrawal-Associated Increases in Heroin Self-Administration: Pharmacologic Modulation of Heroin vs Food Choice in Heroin-Dependent Rhesus Monkeys

  2009cited by this paper
• Monitoring risk: post marketing surveillance and signal detection.

  2009cited by this paper
• Risk management of drug products and the U.S. Food and Drug Administration: evolution and context.

  2009cited by this paper
• Signal detection in post-marketing surveillance for controlled substances.

  2009cited by this paper
• Discriminative Stimulus and Subject-Rated Effects of Methamphetamine, d-Amphetamine, Methylphenidate, and Triazolam in Methamphetamine-Trained Humans

  2009cited by this paper
• Self‐administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls

  2009cited by this paper
• Controversies in translational research: drug self-administration

  2008influential reference
• Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys.

  2008cited by this paper
• Some effects of dopamine transporter and receptor ligands on discriminative stimulus, physiologic, and directly observable indices of opioid withdrawal in rhesus monkeys

  2008cited by this paper
• The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers.

  2008cited by this paper
• Assessing Abuse Liability During Drug Development: Changing Standards and Expectations

  2008influential reference
• Smoked Cocaine Self-Administration is Decreased by Modafinil

  2008cited by this paper
• The role of human drug self-administration procedures in the development of medications.

  2008influential reference
• Non-prescribed use of pain relievers among adolescents in the United States.

  2008cited by this paper
• Foundations of Opioid Risk Management

  2007cited by this paper
• Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.

  2007cited by this paper
• Drug and Reinforcement History as Determinants of the Response-Maintaining Effects of Quinpirole in the Rat

  2007cited by this paper
• Interactions between drugs and occupied receptors.

  2007cited by this paper
• Self-administration of drugs in animals and humans as a model and an investigative tool.

  2007influential reference
• Relative Abuse Liability of Indiplon and Triazolam in Humans: A Comparison of Psychomotor, Subjective, and Cognitive Effects

  2007cited by this paper
• Long-term cocaine self-administration under fixed–ratio and second-order schedules in monkeys

  2007cited by this paper
• Research design strategies to evaluate the impact of formulations on abuse liability.

  2006cited by this paper
• Risk identification, risk assessment, and risk management of abusable drug formulations.

  2006cited by this paper
• Relative Abuse Liability of GHB in Humans: A Comparison of Psychomotor, Subjective, and Cognitive Effects of Supratherapeutic Doses of Triazolam, Pentobarbital, and GHB

  2006cited by this paper
• The Clinical Development of γ-Hydroxybutyrate (GHB)

  2006cited by this paper
• Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.

  2006cited by this paper
• Impact of formulation on the abuse liability, safety and regulation of medications: the expert panel report.

  2006cited by this paper
• The clinical development of gamma-hydroxybutyrate (GHB).

  2006cited by this paper
• Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol.

  2006cited by this paper
• Relative Reinforcing Effects of Cocaine, Remifentanil, and Their Combination in Rhesus Monkeys

  2006cited by this paper
• Development of opioid formulations with limited diversion and abuse potential.

  2006cited by this paper
• Replacing relative reinforcing efficacy with behavioral economic demand curves.

  2006cited by this paper
• Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.

  2006cited by this paper
• Acute and chronic effects of ramelteon in rhesus monkeys (Macaca mulatta): dependence liability studies.

  2006cited by this paper
• Subjective and behavioral effects of diazepam depend on its rate of onset

  2005cited by this paper
• Cocaine self-administration under fixed and progressive ratio schedules of reinforcement: comparison of C57BL/6J, 129X1/SvJ, and 129S6/SvEvTac inbred mice

  2005cited by this paper
• Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats

  2005influential reference
• Discriminative Stimulus Effects of γ-Hydroxybutyrate (GHB) in Rats Discriminating GHB from Baclofen and Diazepam

  2005cited by this paper
• The Xyrem® Risk Management Program

  2004cited by this paper
• The Discriminative Stimulus Effects of γ-Hydroxybutyrate and Related Compounds in Rats Discriminating Baclofen or Diazepam: The Role of GABAB and GABAA Receptors

  2004cited by this paper
• Self-administration of Delta(9)-tetrahydrocannabinol (THC) bydrug naive squirrel monkeys

  2004cited by this paper
• Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans.

  2004cited by this paper
• Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy.

  2004cited by this paper
• The Discriminative stimulus effects of gamma-hydroxybutyrate and related compounds in rats discriminating baclofen or diazepam: The role of GABA(B) and GABA(A) receptors.

  2004cited by this paper
• Assessing abuse liability in clinical trials.

  2003cited by this paper
• The Role of GABAB Receptors in the Discriminative Stimulus Effects of γ-Hydroxybutyrate in Rats: Time Course and Antagonism Studies

  2003cited by this paper
• Guidelines and methodological reviews concerning drug abuse liability assessment.

  2003influential reference
• Self-administration of Δ9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys

  2003cited by this paper
• Principles of drug abuse liability assessment in laboratory animals.

  2003influential reference
• Incorporating the assessment of abuse liability into the drug discovery and development process.

  2003cited by this paper
• An independent assessment of MEDWatch reporting for abuse/dependence and withdrawal from Ultram (tramadol hydrochloride).

  2003cited by this paper
• Principles of initial experimental drug abuse liability assessment in humans.

  2003influential reference
• The Abrupt Cessation of Therapeutically Administered Sodium Oxybate (GHB) Does Not Cause Withdrawal Symptoms

  2003cited by this paper
• The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms

  2003cited by this paper
• Flavor improvement does not increase abuse liability of nicotine chewing gum.

  2002cited by this paper
• Transduction of the discriminative stimulus effects of zolpidem by GABAA/α1 receptors

  2000cited by this paper
• Abuse liability assessment of sibutramine, a novel weight control agent

  2000cited by this paper
• Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons.

  2000cited by this paper
• Conditioned place preference: what does it add to our preclinical understanding of drug reward?

  2000cited by this paper
• Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids

  2000cited by this paper
• Deconstructing relative reinforcing efficacy and situating the measures of pharmacological reinforcement with behavioral economics: a theoretical proposal

  2000cited by this paper
• Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys

  2000cited by this paper
• Effects of agonist-antagonist opioids in humans trained in a hydromorphone/not hydromorphone discrimination.

  2000cited by this paper
• Transduction of the discriminative stimulus effects of zolpidem by GABA(A)/alpha1 receptors.

  2000cited by this paper
• Identifying appropriate subjects for abuse liability studies using prestudy pharmacological testing.

  1999cited by this paper
• Discriminative stimulus effects of flumazenil in untreated and in diazepam-treated rhesus monkeys

  1999cited by this paper
• Zaleplon and triazolam in humans: acute behavioral effects and abuse potential

  1999cited by this paper
• Discriminative stimulus effects of zolpidem in squirrel monkeys: comparison with conventional benzodiazepines and sedative-hypnotics.

  1999cited by this paper
• A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States.

  1999cited by this paper
• Evaluation of the reinforcing and discriminative stimulus effects of gamma-hydroxybutyrate in rhesus monkeys.

  1999influential reference
• Comparison of the intravenous reinforcing effects of propofol and methohexital in baboons.

  1999cited by this paper
• Evaluation of the reinforcing and discriminative stimulus effects of γ-hydroxybutyrate in rhesus monkeys

  1999influential reference
• Repeated administration of flumazenil does not alter its potency in modifying schedule-controlled behavior in chlordiazepoxide-treated rhesus monkeys

  1997cited by this paper
• Benzodiazepine self-administration in humans and laboratory animals – implications for problems of long-term use and abuse

  1997cited by this paper
• Clinical management of antidepressant discontinuation.

  1997cited by this paper
• Reinforcing, subjective, and performance effects of lorazepam and diphenhydramine in humans

  1996cited by this paper
• Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans.

  1996cited by this paper
• Validation of the Multiple-Choice procedure for investigating drug reinforcement in humans

  1996cited by this paper
• Effects of drug discrimination history on the generalization of pentobarbital to other drugs.

  1996cited by this paper
• Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.

  1995cited by this paper
• Drug discrimination: no evidence for tolerance to opiates.

  1995cited by this paper
• Discriminative stimulus effects of diazepam and buspirone in normal volunteers.

  1995cited by this paper
• Normalized demand for drugs and other reinforcers.

  1995influential reference
• Acute administration of buprenorphine in humans: partial agonist and blockade effects.

  1995cited by this paper
• Alprazolam absorption kinetics affects abuse liability *

  1995cited by this paper
• Orally self-administered cocaine in rhesus monkeys: transition from negative or neutral behavioral effects to positive reinforcing effects.

  1993cited by this paper
• Multiple‐choice procedure: an efficient approach for investigating drug reinforcement in humans

  1993cited by this paper
• Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: pharmacological and behavioral characterization of intermediate levels of drug lever selection.

  1993cited by this paper
• Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability.

  1992cited by this paper
• Testing the abuse liability of anxiolytic and hypnotic drugs in humans.

  1991cited by this paper
• Assessment of abuse liability of stimulant drugs in humans: a methodological survey.

  1991cited by this paper
• Human drug abuse liability assessment: opioids and analgesics.

  1991cited by this paper
• Relationship between the discriminative stimulus properties and subjective effects of drugs.

  1988cited by this paper
• Self-administration of orally-delivered methohexital in rhesus monkeys with phencyclidine or pentobarbital histories: effects of food deprivation and satiation.

  1984cited by this paper
• Self-injection of barbiturates and benzodiazepines in baboons

  1981cited by this paper
• The stimulus properties of gamma-hydroxybutyrate.

  1981cited by this paper
• Double-blind evaluation of reinforcing and anorectic actions of weight control medications. Interaction of pharmacological and behavioral treatments.

  1980cited by this paper
• Benzodiazepine self-administration in animals and humans: a comprehensive literature review.

  1980cited by this paper
• [Drug addiction].

  1980cited by this paper
• Opioids: Similarity between evaluations of subjective effects and animal self‐administration results

  1979cited by this paper

• Testing the reinforcing properties of sodium in hyper-palatable and ultra-processed foods using an experimental randomized parallel arm design.

  2026cites this paper
• Bifunctional modulation of NMDA and opioid receptors in ketamine reinforcement and misuse: implications for substance use disorder treatment.

  2025cites this paper
• Locomotor and discriminative stimulus effects of fluorinated analogs of amphetamine and methamphetamine in mice and rats.

  2025cites this paper
• Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users' Patterns of Use and Perceived Effects.

  2025cites this paper
• Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations.

  2025cites this paper
• Cocaine chemogenetics blunts drug-seeking by synthetic physiology

  2025cites this paper
• Preclinical abuse potential testing using behavioral economics and drug self-administration demand-curve analysis: A strategy to improve resolution of drug stratification for regulatory control.

  2025cites this paper
• Low dose baclofen and standard dose acamprosate had comparable changes in brain glutamate, brain Gamma amino butyric acid (GABA) and craving among patients with alcohol dependence syndrome: A 1H-MRS based open label randomized study

  2025cites this paper
• Discriminative stimulus and antinociceptive effects of sixteen nitazene analogs in rodents.

  2025cites this paper
• Abuse potential and analgesic efficacy of intravenous hydromorphone bolus administration among hospitalized patients with cancer pain: A double‐blind, double dummy, randomized crossover trial

  2025cites this paper
• Behavioral effects of three synthetic tryptamine derivatives in rodents

  2025cites this paper
• Nanoparticle-based inhibition of vascular endothelial growth factor receptors alleviates osteoarthritis pain and cartilage damage

  2024cites this paper
• Co-targeting the kappa opioid receptor and dopamine transporter reduces motivation to self-administer cocaine and partially reverses dopamine system dysregulation

  2024cites this paper
• The influence of drug class on reward in substance use disorders.

  2024cites this paper
• Dose by design: How limits on nicotine flux and puff duration affect the abuse liability of electronic nicotine delivery systems.

  2024cites this paper
• Racial/ethnic differences in the acute effects of reduced nicotine content cigarettes among adolescents who smoke.

  2024cites this paper
• Navigating ethical challenges in psychological research involving digital remote technologies and people who use alcohol or drugs.

  2024cites this paper
• Optical Intracranial Self-Stimulation (oICSS): A New Behavioral Model for Studying Drug Reward and Aversion in Rodents

  2024cites this paper
• Assessment of human abuse potential of an unflavored, sucralose-sweetened electronic cigarette in combustible cigarette smokers.

  2024cites this paper
• Drug discrimination learning: Interoceptive stimulus control of behavior and its implications for regulated and dysregulated drug intake.

  2024cites this paper
• Monitoring misuse and abuse of psychoactive substances in France: Insights from substance abuse treatment facilities through the OPPIDUM program.

  2024cites this paper
• Psilocybin and hallucinogenic mushrooms

  2024cites this paper
• Event-level associations among THC, CBD, social context, and subjective effects during Cannabis use episodes

  2024cites this paper
• Rate of onset of dopamine transporter inhibitors assessed with intracranial self-stimulation and in vivo dopamine photometry in rats

  2023cites this paper
• Impact of reduced nicotine content on behavioral economic measures of cigarette reinforcement in adolescents who smoke cigarettes.

  2023cites this paper
• Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective

  2023cites this paper
• μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges

  2023cites this paper
• Selecting the appropriate hurdles and endpoints for pentilludin, a novel antiaddiction pharmacotherapeutic targeting the receptor type protein tyrosine phosphatase D

  2023cites this paper
• Human Abuse Liability Assessment of E-Cigarettes: Why, What and How?

  2022cites this paper
• Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.

  2022cites this paper
• Essential role of P-glycoprotein in the mechanism of action of oliceridine

  2022cites this paper
• Appetitive Pavlovian conditioning of the stimulus effects of nicotine enhances later nicotine self-administration.

  2022cites this paper
• Mini review: Potential therapeutic values of mitragynine as an opioid substitution therapy

  2022cites this paper
• Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability.

  2022cites this paper
• Animal Models to Evaluate Expression, Mechanisms, and Treatment of Pain

  2021cites this paper
• Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability

  2021cites this paper
• Effect of Exposure to e-Cigarettes With Salt vs Free-Base Nicotine on the Appeal and Sensory Experience of Vaping

  2021cites this paper
• Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model

  2021cites this paper
• Demographic characteristics of drug Choosers and Subjective responses predict d-amphetamine choice in healthy volunteers.

  2021cites this paper
• Conceptual model for the evaluation of attractiveness, addictiveness and toxicity of tobacco and related products: The example of JUUL e-cigarettes.

  2021cites this paper
• Sensory methods to evaluate perception of flavours in tobacco and other nicotine-containing products: a review

  2021cites this paper
• Human Abuse Liability Assessment of Tobacco and Nicotine Products: Approaches for Meeting Current Regulatory Recommendations.

  2021cites this paper
• Adolescents’ Understanding of Opioid-Induced Euphoria Measures and Proposed Measurement Revisions

  2021cites this paper
• Study design criteria for regulatory-based drug control action: Drug discrimination.

  2021cites this paper
• Confronting the challenge of failed translation in medications development for substance use disorders

  2021cites this paper
• Abuse Deterrent Formulations in Constraining the Abuse Potential of Prescription Medicines: A Myth or Truth.

  2021cites this paper
• The self-serving benefits of being a good host: A role for our micro-inhabitants in shaping opioids' function.

  2021cites this paper
• Acute drug effects differentially predict desire to take dextroamphetamine again for work and recreation

  2021cites this paper
• Discriminative Stimulus Effects of Substituted Tryptamines in Rats.

  2020cites this paper
• Cross-reinstatement of mitragynine and morphine place preference in rats.

  2020cites this paper
• New Biological Insights into Smoking Cessation

  2020cites this paper
• Effect of physical manipulation on the oral pharmacokinetic profile of Xtampza® ER (oxycodone DETERx® formulation): A review of published studies.

  2020cites this paper
• Response to opioids is dependent on sociability levels

  2020cites this paper
• Smokeless tobacco product design and marketing: targeting new populations in a changing regulatory environment

  2020cites this paper
• Pre-exposure of adolescent mice to morphine results in stronger sensitization and reinstatement of conditioned place preference than pre-exposure to hydrocodone

  2020cites this paper
• Behavioral economic measurement of cigarette demand: A descriptive review of published approaches to the cigarette purchase task.

  2020cites this paper
• Interaction of Ethanol and Oral ANS-6637, a Selective ALDH2 Inhibitor in Males: A Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Cohort Study.

  2020cites this paper
• Behavioral, neurobiological, and neurochemical mechanisms of ethanol self-administration: A translational review.

  2020cites this paper
• Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing

  2020cites this paper
• The Rise and Fall of Kappa-Opioid Receptors in Drug Abuse Research.

  2019cites this paper
• A Systematic Review of Laboratory Evidence for the Abuse Potential of Tramadol in Humans

  2019cites this paper
• Locomotor activity and discriminative stimulus effects of five novel synthetic cathinone analogs in mice and rats.

  2019cites this paper
• Effects of non-tobacco flavors and nicotine on e-cigarette product appeal among young adult never, former, and current smokers.

  2019cites this paper
• Establishing performance characteristics for positive control article selection in drug self-administration studies.

  2019cites this paper
• Effects of ketamine treatment on cocaine-induced reinstatement and disruption of functional connectivity in unanesthetized rhesus monkeys

  2019cites this paper
• Abuse liability assessment of an electronic cigarette in combustible cigarette smokers.

  2019cites this paper
• Understanding Addiction Using Animal Models

  2019cites this paper
• Individual differences in human opioid abuse potential as observed in a human laboratory study.

  2019cites this paper
• Subjective effects of combustible, vaporized, and edible cannabis: Results from a survey of adolescent cannabis users.

  2019cites this paper
• Core Outcome Measures in Preclinical Assessment of Candidate Analgesics

  2019cites this paper
• Investigating the anti-cocaine, anti-nociceptive properties and side effects of MP1104, a novel mixed opioid receptor agonist

  2019influential citation
• 21st century neurobehavioral theories of decision making in addiction: Review and evaluation

  2018cites this paper
• Efficacy and safety of naltrexone for amfetamine and methamfetamine use disorder: a systematic review of randomized controlled trials

  2018cites this paper
• Abuse Potential of Biased Mu Opioid Receptor Agonists.

  2018cites this paper
• Sweet flowers are slow, and weeds make haste: leveraging methodology from research on tobacco, alcohol, and opioid analgesics to make rapid and policy-relevant advances in cannabis science

  2018cites this paper
• Evaluation of morphine‐like effects of the mixed mu/delta agonist morphine‐6‐O‐sulfate in rats: Drug discrimination and physical dependence

  2018cites this paper
• Drug liking and wanting, not impulsive action or reflection is increased by 4-fluoroamphetamine

  2018cites this paper
• Abuse liability assessment for biologic drugs – All molecules are not created equal

  2018cites this paper
• Characterizing the subjective, observer-rated, and physiological effects of hydromorphone relative to heroin in a human laboratory study

  2018cites this paper
• Behavioural and Pharmacological Interactions between Drug and Nutritional Reinforcers

  2018cites this paper
• The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act

  2018cites this paper
• Behaviour and Neural Indices of the Abuse Liability associated with Intraoral Self-administration of High Fructose Corn Syrup

  2018influential citation
• Subjective Cannabis Effects as Part of a Developing Disorder in Adolescents and Emerging Adults

  2018cites this paper
• Ultrasonic Vocalizations Capture Opposing Affective States During Drug Self-Administration: Revisiting the Opponent-Process Model of Addiction

  2018cites this paper
• A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor

  2018cites this paper
• Electronic Cigarette User Plasma Nicotine Concentration, Puff Topography, Heart Rate, and Subjective Effects: Influence of Liquid Nicotine Concentration and User Experience

  2017cites this paper
• Utility of Nonhuman Primates in Substance Use Disorders Research.

  2017cites this paper
• Foods are differentially associated with subjective effect report questions of abuse liability

  2017cites this paper
• Inhalation of Alcohol Vapor: Measurement and Implications

  2017cites this paper
• Locomotor activity and discriminative stimulus effects of a novel series of synthetic cathinone analogs in mice and rats

  2017cites this paper
• Abuse-related effects of subtype-selective GABAA receptor positive allosteric modulators in an assay of intracranial self-stimulation in rats

  2017cites this paper
• Effects of Early Adolescent Exposure to d -Amphetamine in a Rodent Model of Nicotine Reward

  2017cites this paper
• Non-medical and illicit use of psychoactive drugs

  2017cites this paper
• Current Strategies for Abuse Liability Assessment of New Chemical Entities

  2017cites this paper
• Parallel role for the dopamine D1 receptor in gambling and amphetamine reinforcement in healthy volunteers

  2017cites this paper
• Measures That Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: ACTTION Critique and Recommended Considerations.

  2017cites this paper
• Craving and Acute Effects of Alcohol in Youths’ Daily Lives: Associations With Alcohol Use Disorder Severity

  2017cites this paper
• Nanomedicine: Going small to beat the high.

  2016cites this paper
• The Abuse Potential of Prescription Opioids in Humans-Closing in on the First Century of Research.

  2016cites this paper
• Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trial

  2016cites this paper